Literature DB >> 9796656

Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies.

P Y Bello1, C Pasquier, P Gourney, J Puel, J Izopet.   

Abstract

The performance of a commercially available assay for detection of hepatitis C virus (HCV) antibody in saliva samples was assessed. Samples of saliva were collected from 270 individuals whose HCV antibody status was determined by serum assay (161 HCV-positive, 109 HCV-negative). The saliva samples were tested for the presence of HCV antibodies using a modified protocol. The sensitivity was 94.4% (95% CI, 89.3-97.2%) and the specificity 99.1% (95% CI, 94.3-100%). Although the optical density in tests on HIV-positive individuals was lower than that among HIV-negative individuals, the HIV status had no significant influence on the results of the HCV assay in saliva. These findings suggest that tests on saliva can be useful in epidemiological studies for estimating the prevalence of HCV in populations that are difficult to reach.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796656     DOI: 10.1007/bf01708621

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  The use of oral fluid for hepatitis C antibody screening.

Authors:  K E Sherman; R L Creager; J O'Brien; S Sargent; S Piacentini; T Thieme
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

2.  Accuracy of a saliva test for HIV antibody.

Authors:  R R Frerichs
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-12-01

3.  Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine.

Authors:  J A Connell; J V Parry; P P Mortimer; J Duncan
Journal:  J Med Virol       Date:  1993-10       Impact factor: 2.327

4.  Modified enzyme immunoassay to detect hepatitis C virus antibodies in oral fluid.

Authors:  P G McIntyre; J Laszlo; K Appleyard; G R Ogden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

Review 5.  Hepatitis C virus diagnostics: technology, clinical applications and impacts.

Authors:  C Conry-Cantilena
Journal:  Trends Biotechnol       Date:  1997-02       Impact factor: 19.536

6.  Saliva-based HIV-antibody testing in Thailand.

Authors:  R R Frerichs; N Silarug; N Eskes; P Pagcharoenpol; A Rodklai; S Thangsupachai; C Wongba
Journal:  AIDS       Date:  1994-07       Impact factor: 4.177

7.  A modified ELISA and western blot accurately determine anti-human immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting device.

Authors:  W W Emmons; S F Paparello; C F Decker; J M Sheffield; F H Lowe-Bey
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

8.  HIV infection in injecting drug users attending centres in England and Wales, 1990-1991.

Authors:  A Noone; A J Durante; A R Brady; F Majid; A V Swan; J V Parry; G J Hart; J A Connell; K R Perry; R E Joce
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

9.  Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis.

Authors:  T Thieme; P Yoshihara; S Piacentini; M Beller
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

10.  High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.

Authors:  B Cribier; D Rey; C Schmitt; J M Lang; A Kirn; F Stoll-Keller
Journal:  AIDS       Date:  1995-10       Impact factor: 4.177

  10 in total
  7 in total

1.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

2.  Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum.

Authors:  L Cock De; V Hutse; R Vranckx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  Evaluation of saliva specimens as an alternative sampling method to detect hepatitis B surface antigen.

Authors:  Helena Medina Cruz; Elisangela Ferreira da Silva; Cristiane A Villela-Nogueira; Letícia C Nabuco; Kycia Maria Rodrigues do Ó; Lia Laura Lewis-Ximenez; Clara Fumiko Tachibana Yoshida; Elisabeth Lampe; Livia Melo Villar
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

4.  Importance of collection methods and stability of oral fluid samples for hepatitis B surface antigen detection.

Authors:  Letícia de Paula Scalioni; Helena Medina Cruz; Vanessa Salete de Paula; Jaqueline Corrêia Oliveira; Renata Tourinho Dos Santos; Ana Rita Coimbra Motta-Castro; Paula Guerra Murat; Cristiane Alves Villela-Nogueira; Lia Laura Lewis-Ximenez; Elisabeth Lampe; Livia Melo Villar
Journal:  J Clin Lab Anal       Date:  2013-02-25       Impact factor: 2.352

5.  Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies.

Authors:  V González; E Martró; C Folch; A Esteve; L Matas; A Montoliu; J R Grífols; F Bolao; C Tural; R Muga; J V Parry; V Ausina; J Casabona
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-20       Impact factor: 3.267

6.  Detection of Hepatitis C Virus RNA in Blood and Saliva of Transfusion-Dependent Thalassemia Patients Diagnosed with Hepatitis C.

Authors:  Behzad Hooshmand; Seyed Moayed Alavian; Farnaz Kouhestani; Maryam Firouzmandi; Saeed Reza Motamedian
Journal:  Contemp Clin Dent       Date:  2018 Jan-Mar

7.  The use of salivary cytokines as a screening tool for oral squamous cell carcinoma : A review of the literature.

Authors:  Tarig A Osman; Daniela E Costea; Anne C Johannessen
Journal:  J Oral Maxillofac Pathol       Date:  2012-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.